雜志介紹

Cancer Management And Research雜志介紹

《Cancer Management And Research》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)癌癥管理與研究，本刊主要出版、報(bào)道醫(yī)學(xué)-ONCOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.5，最新CiteScore 指數(shù)為7.4。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma

  Author: Zhang, Guojun; Yang, Chuan; Zhao, Caixia; Xian, Feng; Qing, Dong; Guo, Qiyu; Song, Junmei; Liu, Xilin; Bie, Jun

• Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?

  Author: Yang, Mingyu; Li, Meng; Lyu, Zhuozhen; Yang, Zhen

• Enhanced Glycolysis Confers Resistance Against Photon but Not Carbon Ion Irradiation in Human Glioma Cell Lines

  Author: Vashishta, Mohit; Kumar, Vivek; Guha, Chandan; Wu, Xiaodong; Dwarakanath, Bilikere S.

• TP63 Functions as a Tumor Suppressor Regulated by GAS5/miR-221-3p Signaling Axis in Human Non-Small Cell Lung Cancer Cells

  Author: Shen, Qiming; Wang, Haoyou; Zhang, Lin

英文介紹

Cancer Management And Research雜志英文介紹

Cancer Management and Research is an international, peer reviewed, open access journal focusing on cancer research and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for cancer patients. Specific topics covered in the journal include:

?Epidemiology, detection and screening

?Cellular research and biomarkers

?Identification of biotargets and agents with novel mechanisms of action

?Optimal clinical use of existing anticancer agents, including combination therapies

?Radiation and surgery

?Palliative care

?Patient adherence, quality of life, satisfaction

The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, and case series that shed novel insights on a disease or disease subtype.